Description |
protein inhibitor of activated STAT 3 |
estrogen receptor 2 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Diethylstilbestrol
- Raloxifene
- Estrone
- Tamoxifen
- Estradiol
- Trilostane
- Estramustine
- Oxybenzone
- Genistein
- Prasterone
- Benzophenone
- Phthalic Acid
- Pyrazole
- Para-Mercury-Benzenesulfonic Acid
- Naringenin
- N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide
- 5-Alpha-Androstane-3-Beta,17beta-Diol
- 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
- Quercetin
- Afimoxifene
- Estriol
- Estrone sulfate
- MF101
- CHF 4227
- Lasofoxifene
- Bazedoxifene
- 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
- 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
- [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
- 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
- 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
- 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
- (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
- 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
- 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
- 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
- 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE
- 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
- (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL
- (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
- Erteberel
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- Eugenol
- Octocrylene
- Enzacamene
- Equol
- 2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol
|
Diseases |
|
|
GWAS |
|
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Atrial fibrillation ( 30061737)
- Chronotype ( 30696823)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Depression ( 29700475)
- Hematocrit ( 27863252)
- Hemoglobin concentration ( 27863252)
- Metabolite levels ( 23823483)
- Prostate cancer ( 26443449)
- Red blood cell count ( 27863252)
|
Interacting Genes |
54 interacting genes:
AR
ATF7IP
CARHSP1
CBS
CREBBP
CREM
EP300
ESR1
ESR2
GEMIN4
GFI1
GLUL
HABP4
HDAC1
HMGA2
MITF
NCOA2
NR3C2
OPN1LW
PGR
PPP1CA
PRPF40A
PSMC1
RAC1
RELA
REX1BD
SATB1
SENP1
SERBP1
SERPINA10
SIAH1
SIAH2
SKIL
SMAD2
SMAD3
SMAD4
SNAI2
SNIP1
SPOP
SREBF2
STAT3
SUMO1
SUMO2
SUMO3
TBP
TRIM27
TRIM32
TRIM55
TRIM63
UBA1
UBE2I
ZFHX3
ZMIZ1
ZMIZ2
|
98 interacting genes:
AGR3
AKAP13
AKT1
ARID5A
BCAS2
CALM1
CALM2
CALM3
CASC3
CASZ1
CCNC
CDK8
DAP3
DDX54
DKK3
DNMT3L
DNTTIP2
EP300
ESR1
IL13RA2
IL24
ITIH5
JMJD1C
KAT5
KLK9
LCK
LRATD2
MAD2L1
MAPK1
MAPK11
MED1
MED10
MED12
MED14
MED16
MED17
MED20
MED21
MED23
MED24
MED6
MED7
MEOX2
MKNK2
MMS19
MRC2
MSH2
NCOA1
NCOA2
NCOA3
NCOA6
NCOA7
NCOR1
NCOR2
NFKBIB
NOTCH2NLA
NR0B1
NR0B2
NRIP1
OXT
PELP1
PIAS1
PIAS2
PIAS3
PLSCR1
PNRC1
PNRC2
PPARGC1A
PPP5C
PRMT2
PRSS50
PSMC3IP
PSMC5
RBFOX2
RBM39
REXO4
RFX6
SERPINH1
SMAD2
SMAD3
SMAD4
SMARCE1
SP1
SRA1
SRC
SREBF1
STAT5A
TFF1
TRAM1
TRIM24
TRIM59
TRIP4
TXNRD1
WIPI1
YWHAH
YWHAQ
ZBTB17
ZNHIT3
|
Entrez ID |
10401 |
2100 |
HPRD ID |
09068 |
03390 |
Ensembl ID |
ENSG00000131788
|
ENSG00000140009
|
Uniprot IDs |
B3KNI3
Q9Y6X2
|
A0A348FV93
F1D8N3
Q0PTK2
Q7LCB3
Q92731
|
PDB IDs |
4MVT
|
1L2J
1NDE
1QKM
1U3Q
1U3R
1U3S
1U9E
1X76
1X78
1X7B
1X7J
1YY4
1YYE
1ZAF
2FSZ
2GIU
2I0G
2JJ3
2NV7
2QTU
2YJD
2YLY
2Z4B
3OLL
3OLS
3OMO
3OMP
3OMQ
4J24
4J26
4ZI1
5TOA
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|